Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDR | P35968 | 12/20 | 0.62 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | CA9 | Q16790 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | KLK7 | P49862 | 1/20 | 0.47 |
| ▸ | KLK14 | Q9P0G3 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | BRAF | P15056 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | ENPP3 | O14638 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL787774 | 0.95 | KDR (0.65) | KDRMEN1KMT2ACA9MAPT | |
| SCHEMBL787384 | 0.93 | KDR (0.67) | KDRMEN1KMT2ACA9MAPT | |
| SCHEMBL788376 | 0.89 | KDR (0.63) | KDRMEN1KMT2ACA9MAPT | |
| SCHEMBL787689 | 0.89 | KDR (0.63) | KDRMEN1KMT2ACA9MAPT | |
| SCHEMBL788206 | 0.89 | KDR (0.62) | KDRMEN1KMT2ACA9MAPT | |
| SCHEMBL788119 | 0.89 | KDR (0.70) | KDRMEN1KMT2ACA9MAPT | |
| SCHEMBL787842 | 0.89 | KDR (0.65) | KDRMEN1KMT2ACA9MAPT | |
| SCHEMBL787904 | 0.88 | KDR (0.57) | KDRMEN1KMT2ACA9KLK7 | |
| SCHEMBL788076 | 0.88 | KDR (0.61) | KDRMEN1KMT2ACA9MAPT | |
| SCHEMBL788243 | 0.87 | KDR (0.66) | KDRMEN1KMT2ACA9MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2616443-A1 | PHTALAZINE DERIVATIVES AS JAK1 INHIBITORS | Exelixis, Inc. (US) | 2013-07-24 | — | — | EP | claimed |
| WO-2012037132-A1 | PHTALAZINE DERIVATIVES AS JAK1 INHIBITORS | EXELIXIS, INC. (US) | 2012-03-22 | — | — | WO | claimed |